Epidemiological epidemiological E Ep Epi Epid l al cal ical BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 0 3 0
studies studies s st stu stud s es ies dies BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 3 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 3 0
large large l la lar larg e ge rge arge BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 3 0
scale scale s sc sca scal e le ale cale BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 3 0
clini clini c cl cli clin i ni ini lini BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 3 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 3 0
cal cal c ca cal cal l al cal cal BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
trials trials t tr tri tria s ls als ials BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
statin statin s st sta stat n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
class class c cl cla clas s ss ass lass BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 4 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
drugs drugs d dr dru drug s gs ugs rugs BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
have have h ha hav have e ve ave have BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
conclusively conclusively c co con conc y ly ely vely BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
shown shown s sh sho show n wn own hown BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
the the t th the the e he the the BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
association association a as ass asso n on ion tion BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
between between b be bet betw n en een ween BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
reduced reduced r re red redu d ed ced uced BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
low low l lo low low w ow low low BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 4 0
density density d de den dens y ty ity sity BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 4 0
lipoprotein lipoprotein l li lip lipo n in ein tein BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 0 4 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 0 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 0 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 0 4 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
decreased decreased d de dec decr d ed sed ased BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
morbidity morbidity m mo mor morb y ty ity dity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
mortality mortality m mo mor mort y ty ity lity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
from from f fr fro from m om rom from BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
coro coro c co cor coro o ro oro coro BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 4 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 4 0
nary nary n na nar nary y ry ary nary BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
heart heart h he hea hear t rt art eart BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
disease disease d di dis dise e se ase ease BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 0 5 0
CHD chd C CH CHD CHD D HD CHD CHD BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 0 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 0 5 0
1 1 1 1 1 1 1 1 1 1 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 0 5 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 0 5 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 0 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 0 5 0
But but B Bu But But t ut But But BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 0 5 0
despite despite d de des desp e te ite pite BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
these these t th the thes e se ese hese BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
demonstrated demonstrated d de dem demo d ed ted ated BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
benefits benefits b be ben bene s ts its fits BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 0 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 5 0
C c C C C C C C C C BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 0 5 0
levels levels l le lev leve s ls els vels BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 0 5 0
many many m ma man many y ny any many BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
receiving receiving r re rec rece g ng ing ving BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 5 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
therapies therapies t th the ther s es ies pies BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
fail fail f fa fai fail l il ail fail BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
reach reach r re rea reac h ch ach each BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 0 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 5 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 0 5 0
levels levels l le lev leve s ls els vels BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
recommended recommended r re rec reco d ed ded nded BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
current current c cu cur curr t nt ent rent BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
guidelines guidelines g gu gui guid s es nes ines BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
4 4 4 4 4 4 4 4 4 4 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 0 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 0 5 0
The the T Th The The e he The The BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 0 5 0
need need n ne nee need d ed eed need BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
more more m mo mor more e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
effective effective e ef eff effe e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 5 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 5 0
has has h ha has has s as has has BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
encouraged encouraged e en enc enco d ed ged aged BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
greater greater g gr gre grea r er ter ater BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
use use u us use use e se use use BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
higher higher h hi hig high r er her gher BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
doses doses d do dos dose s es ses oses BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
established established e es est esta d ed hed shed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 0 6 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
also also a al als also o so lso also BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
prompted prompted p pr pro prom d ed ted pted BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
efforts efforts e ef eff effo s ts rts orts BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
develop develop d de dev deve p op lop elop BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
more more m mo mor more e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
potent potent p po pot pote t nt ent tent BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
drugs drugs d dr dru drug s gs ugs rugs BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
novel novel n no nov nove l el vel ovel BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
modes modes m mo mod mode s es des odes BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
action action a ac act acti n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
that that t th tha that t at hat that BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
can can c ca can can n an can can BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
be be b be be be e be be be BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
used used u us use used d ed sed used BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
achieve achieve a ac ach achi e ve eve ieve BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
greater greater g gr gre grea r er ter ater BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
reductions reductions r re red redu s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 0 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 6 0
C c C C C C C C C C BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 0 6 0
levels levels l le lev leve s ls els vels BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 0 6 0
broad broad b br bro broa d ad oad road BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
spectrum spectrum s sp spe spec m um rum trum BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 6 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 0 6 0
Therapeutic therapeutic T Th The Ther c ic tic utic BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 0 7 0
hypothesis hypothesis h hy hyp hypo s is sis esis BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
Statins statins S St Sta Stat s ns ins tins BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 0 7 0
inhibit inhibit i in inh inhi t it bit ibit BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
enzyme enzyme e en enz enzy e me yme zyme BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 0 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 7 0
hydroxy hydroxy h hy hyd hydr y xy oxy roxy BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 7 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 0 7 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 7 0
methylglutaryl methylglutaryl m me met meth l yl ryl aryl BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 0 7 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 0 7 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 0 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 0 7 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 0 7 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 0 7 0
reductase reductase r re red redu e se ase tase BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 0 7 0
which which w wh whi whic h ch ich hich BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 0 7 0
catalyses catalyses c ca cat cata s es ses yses BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
conversion conversion c co con conv n on ion sion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 7 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 7 0
to to t to to to o to to to BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
mevalonate mevalonate m me mev meva e te ate nate BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 7 0
an an a an an an n an an an BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
early early e ea ear earl y ly rly arly BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
rate rate r ra rat rate e te ate rate BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 7 0
limiting limiting l li lim limi g ng ing ting BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
step step s st ste step p ep tep step BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
in in i in in in n in in in BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 7 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
biosynthesis biosynthesis b bi bio bios s is sis esis BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
1 1 1 1 1 1 1 1 1 1 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 1 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 1 8 0
This this T Th Thi This s is his This BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 8 0
inhibition inhibition i in inh inhi n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
leads leads l le lea lead s ds ads eads BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
to to t to to to o to to to BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
reductions reductions r re red redu s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 8 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 1 8 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
through through t th thr thro h gh ugh ough BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
two two t tw two two o wo two two BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 8 0
mechanisms mechanisms m me mec mech s ms sms isms BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
: : : : : : : : : : BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 1 2 0
first first f fi fir firs t st rst irst BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 2 0
through through t th thr thro h gh ugh ough BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
reduction reduction r re red redu n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
in in i in in in n in in in BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
mevalonate mevalonate m me mev meva e te ate nate BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 2 0
which which w wh whi whic h ch ich hich BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
leads leads l le lea lead s ds ads eads BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 1 2 0
reduction reduction r re red redu n on ion tion BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
in in i in in in n in in in BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
regulatory regulatory r re reg regu y ry ory tory BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
sterol sterol s st ste ster l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
pool pool p po poo pool l ol ool pool BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 2 0
resulting resulting r re res resu g ng ing ting BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
in in i in in in n in in in BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
upregulation upregulation u up upr upre n on ion tion BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
hepatic hepatic h he hep hepa c ic tic atic BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 2 0
receptors receptors r re rec rece s rs ors tors BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
that that t th tha that t at hat that BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
mediate mediate m me med medi e te ate iate BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
clearance clearance c cl cle clea e ce nce ance BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 2 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 2 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 1 2 0
from from f fr fro from m om rom from BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 2 0
plasma plasma p pl pla plas a ma sma asma BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 1 3 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
second second s se sec seco d nd ond cond BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 3 0
through through t th thr thro h gh ugh ough BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
inhibition inhibition i in inh inhi n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
hepatic hepatic h he hep hepa c ic tic atic BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
synthesis synthesis s sy syn synt s is sis esis BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
very very v ve ver very y ry ery very BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 3 0
low low l lo low low w ow low low BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 3 0
density density d de den dens y ty ity sity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
lipo lipo l li lip lipo o po ipo lipo BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 3 0
protein protein p pr pro prot n in ein tein BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 1 3 0
VLDL vldl V VL VLD VLDL L DL LDL VLDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 3 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 1 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
precursor precursor p pr pre prec r or sor rsor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 3 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 1 3 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 1 3 0
Statins statins S St Sta Stat s ns ins tins BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 3 0
also also a al als also o so lso also BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
reduce reduce r re red redu e ce uce duce BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
triglycerides triglycerides t tr tri trig s es des ides BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 1 3 0
increased increased i in inc incr d ed sed ased BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
which which w wh whi whic h ch ich hich BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 1 3 0
risk risk r ri ris risk k sk isk risk BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
factor factor f fa fac fact r or tor ctor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
for for f fo for for r or for for BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
CHD chd C CH CHD CHD D HD CHD CHD BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 3 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 1 3 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
increase increase i in inc incr e se ase ease BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
high high h hi hig high h gh igh high BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 3 0
density density d de den dens y ty ity sity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 3 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 3 0
lipoprotein lipoprotein l li lip lipo n in ein tein BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 1 4 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 1 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 4 0
decreased decreased d de dec decr d ed sed ased BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
levels levels l le lev leve s ls els vels BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
which which w wh whi whic h ch ich hich BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 1 4 0
risk risk r ri ris risk k sk isk risk BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
factor factor f fa fac fact r or tor ctor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
CHD chd C CH CHD CHD D HD CHD CHD BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 1 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 1 4 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 1 4 0
The the T Th The The e he The The BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 4 0
first first f fi fir firs t st rst irst BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
statin statin s st sta stat n in tin atin BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
, , , , , , , , , , BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 4 0
lovastatin lovastatin l lo lov lova n in tin atin BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 1 4 0
Mevacor mevacor M Me Mev Meva r or cor acor BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 4 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 1 4 0
Merck merck M Me Mer Merc k ck rck erck BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 1 4 0
, , , , , , , , , , BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 4 0
was was w wa was was s as was was BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
marketed marketed m ma mar mark d ed ted eted BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
1987 1987 1 19 198 1987 7 87 987 1987 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 1 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 4 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
1998 1998 1 19 199 1998 8 98 998 1998 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 1 4 0
had had h ha had had d ad had had BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
been been b be bee been n en een been BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
joined joined j jo joi join d ed ned ined BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 1 4 0
Zocor zocor Z Zo Zoc Zoco r or cor ocor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 4 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 1 4 0
Merck merck M Me Mer Merc k ck rck erck BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 1 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 1 4 0
pravas pravas p pr pra prav s as vas avas BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 4 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 4 0
tatin tatin t ta tat tati n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 1 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 1 5 0
Pravachol pravachol P Pr Pra Prav l ol hol chol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 5 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 1 5 0
Bristol bristol B Br Bri Bris l ol tol stol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 1 5 0
Myers myers M My Mye Myer s rs ers yers BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 5 0
Squibb squibb S Sq Squ Squi b bb ibb uibb BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 1 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 2 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 5 0
fluvas fluvas f fl flu fluv s as vas uvas BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 2 5 0
tatin tatin t ta tat tati n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 2 5 0
Lescol lescol L Le Les Lesc l ol col scol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 5 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 2 5 0
Novartis novartis N No Nov Nova s is tis rtis BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 2 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 5 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 2 5 0
Lipitor lipitor L Li Lip Lipi r or tor itor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 5 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 2 5 0
Pfizer pfizer P Pf Pfi Pfiz r er zer izer BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 2 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 5 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
cerivastatin cerivastatin c ce cer ceri n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 2 5 0
Baycol baycol B Ba Bay Bayc l ol col ycol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 5 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 2 5 0
Bayer bayer B Ba Bay Baye r er yer ayer BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 2 5 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 5 0
although although a al alt alth h gh ugh ough BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
cerivastatin cerivastatin c ce cer ceri n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
was was w wa was was s as was was BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
withdrawn withdrawn w wi wit with n wn awn rawn BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
from from f fr fro from m om rom from BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
market market m ma mar mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
2001 2001 2 20 200 2001 1 01 001 2001 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 2 5 0
because because b be bec beca e se use ause BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 2 5 0
large large l la lar larg e ge rge arge BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
number number n nu num numb r er ber mber BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
reported reported r re rep repo d ed ted rted BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
cases cases c ca cas case s es ses ases BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
rhabdomyolysis rhabdomyolysis r rh rha rhab s is sis ysis BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 2 5 0
severe severe s se sev seve e re ere vere BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 5 0
muscular muscular m mu mus musc r ar lar ular BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
toxicity toxicity t to tox toxi y ty ity city BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 2 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 6 0
some some s so som some e me ome some BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
which which w wh whi whic h ch ich hich BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
were were w we wer were e re ere were BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
fatal fatal f fa fat fata l al tal atal BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 2 6 0
Drug drug D Dr Dru Drug g ug rug Drug BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 2 6 0
properties properties p pr pro prop s es ies ties BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 2 6 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 OPENBRACKET 2 6 0
FIG fig F FI FIG FIG G IG FIG FIG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 2 6 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 2 6 0
1 1 1 1 1 1 1 1 1 1 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 2 6 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 2 6 0
was was w wa was was s as was was BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
discovered discovered d di dis disc d ed red ered BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
through through t th thr thro h gh ugh ough BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
synthesis synthesis s sy syn synt s is sis esis BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
screening screening s sc scr scre g ng ing ning BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 2 6 0
series series s se ser seri s es ies ries BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
pyrimidine pyrimidine p py pyr pyri e ne ine dine BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 2 6 0
substituted substituted s su sub subs d ed ted uted BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 2 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 6 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 2 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 2 6 0
dihydroxy dihydroxy d di dih dihy y xy oxy roxy BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 2 6 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 2 6 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 2 6 0
heptenoates heptenoates h he hep hept s es tes ates BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
containing containing c co con cont g ng ing ning BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 2 7 0
sulphonyl sulphonyl s su sul sulp l yl nyl onyl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
moiety moiety m mo moi moie y ty ety iety BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
introduced introduced i in int intr d ed ced uced BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
lower lower l lo low lowe r er wer ower BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
lipophilicity lipophilicity l li lip lipo y ty ity city BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
thereby thereby t th the ther y by eby reby BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
improve improve i im imp impr e ve ove rove BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
selectivity selectivity s se sel sele y ty ity vity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
liver liver l li liv live r er ver iver BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 2 7 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 2 7 0
In in I In In In n In In In BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 7 0
addition addition a ad add addi n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 7 0
lower lower l lo low lowe r er wer ower BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
lipophilicity lipophilicity l li lip lipo y ty ity city BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
might might m mi mig migh t ht ght ight BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
be be b be be be e be be be BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
associated associated a as ass asso d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
with with w wi wit with h th ith with BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
reduced reduced r re red redu d ed ced uced BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
metabolism metabolism m me met meta m sm ism lism BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
cytochrome cytochrome c cy cyt cyto e me ome rome BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
P450s p450s P P4 P45 P450 s 0s 50s 450s BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 NOPUNCT 2 7 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 2 7 0
Unlike unlike U Un Unl Unli e ke ike like BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 7 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 2 7 0
number number n nu num numb r er ber mber BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
other other o ot oth othe r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 7 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 7 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
not not n no not not t ot not not BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
metabolized metabolized m me met meta d ed zed ized BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
significantly significantly s si sig sign y ly tly ntly BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
by by b by by by y by by by BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
cytochrome cytochrome c cy cyt cyto e me ome rome BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
P450 p450 P P4 P45 P450 0 50 450 P450 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 2 8 0
3A4 3a4 3 3A 3A4 3A4 4 A4 3A4 3A4 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 2 8 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 8 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
major major m ma maj majo r or jor ajor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
cytochrome cytochrome c cy cyt cyto e me ome rome BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 8 0
P450 p450 P P4 P45 P450 0 50 450 P450 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 2 2 0
involved involved i in inv invo d ed ved lved BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
drug drug d dr dru drug g ug rug drug BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
metabolism metabolism m me met meta m sm ism lism BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 2 2 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
so so s so so so o so so so BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
has has h ha has has s as has has BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
less less l le les less s ss ess less BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
potential potential p po pot pote l al ial tial BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
drug drug d dr dru drug g ug rug drug BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 2 2 0
drug drug d dr dru drug g ug rug drug BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
interactions interactions i in int inte s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 2 2 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 2 2 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
was was w wa was was s as was was BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
found found f fo fou foun d nd und ound BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 2 2 0
to to t to to to o to to to BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
be be b be be be e be be be BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
more more m mo mor more e re ore more BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
potent potent p po pot pote t nt ent tent BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
than than t th tha than n an han than BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
lovastatin lovastatin l lo lov lova n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 2 0
fluvastatin fluvastatin f fl flu fluv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
pravas pravas p pr pra prav s as vas avas BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 2 0
tatin tatin t ta tat tati n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
inhibiting inhibiting i in inh inhi g ng ing ting BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 3 2 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 2 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 3 2 0
reductase reductase r re red redu e se ase tase BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
vitro vitro v vi vit vitr o ro tro itro BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 NOPUNCT 3 2 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 COMMA 3 2 0
and and a an and and d nd and and BLOCKIN LINESTART ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
more more m mo mor more e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
potent potent p po pot pote t nt ent tent BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
than than t th tha than n an han than BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
pravastatin pravastatin p pr pra prav n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
reducing reducing r re red redu g ng ing cing BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
plasma plasma p pl pla plas a ma sma asma BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 3 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 3 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
vivo vivo v vi viv vivo o vo ivo vivo BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 COMMA 3 3 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
was was w wa was was s as was was BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
therefore therefore t th the ther e re ore fore BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
chosen chosen c ch cho chos n en sen osen BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
clinical clinical c cl cli clin l al cal ical BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
testing testing t te tes test g ng ing ting BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 3 3 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 3 3 0
Clinical clinical C Cl Cli Clin l al cal ical BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 3 3 0
data data d da dat data a ta ata data BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
In in I In In In n In In In BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 3 3 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 3 3 0
six six s si six six x ix six six BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 3 0
week week w we wee week k ek eek week BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 3 0
double double d do dou doub e le ble uble BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 3 0
blind blind b bl bli blin d nd ind lind BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 3 0
placebo placebo p pl pla plac o bo ebo cebo BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 3 0
controlled controlled c co con cont d ed led lled BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 3 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 3 0
study study s st stu stud y dy udy tudy BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
hypercholesterolaemia hypercholesterolaemia h hy hyp hype a ia mia emia BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 4 0
a a a a a a a a a a BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 3 4 0
single single s si sin sing e le gle ngle BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
daily daily d da dai dail y ly ily aily BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 3 4 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 3 4 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 4 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 4 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 4 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 4 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 4 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 3 4 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
significantly significantly s si sig sign y ly tly ntly BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
reduced reduced r re red redu d ed ced uced BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
levels levels l le lev leve s ls els vels BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
total total t to tot tota l al tal otal BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 3 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 4 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 3 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 3 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 4 0
non non n no non non n on non non BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 4 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 3 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 3 4 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
apolipoprotein apolipoprotein a ap apo apol n in ein tein BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
B b B B B B B B B B BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 3 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 3 4 0
Apo apo A Ap Apo Apo o po Apo Apo BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 3 4 0
B b B B B B B B B B BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 3 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 4 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
major major m ma maj majo r or jor ajor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
protein protein p pr pro prot n in ein tein BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 4 0
consituent consituent c co con cons t nt ent uent BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 3 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 3 5 0
across across a ac acr acro s ss oss ross BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
range range r ra ran rang e ge nge ange BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 3 5 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 3 5 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 3 5 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
was was w wa was was s as was was BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
compared compared c co com comp d ed red ared BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
with with w wi wit with h th ith with BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
three three t th thr thre e ee ree hree BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
other other o ot oth othe r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
an an a an an an n an an an BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
open open o op ope open n en pen open BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 5 0
label label l la lab labe l el bel abel BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
study study s st stu stud y dy udy tudy BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
involv involv i in inv invo v lv olv volv BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 5 0
ing ing i in ing ing g ng ing ing BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 3 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 5 0
240 240 2 24 240 240 0 40 240 240 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 5 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
type type t ty typ type e pe ype type BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
IIa iia I II IIa IIa a Ia IIa IIa BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 3 5 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
IIb iib I II IIb IIb b Ib IIb IIb BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 3 5 0
hyper hyper h hy hyp hype r er per yper BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 3 5 0
cholesterolaemia cholesterolaemia c ch cho chol a ia mia emia BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 3 5 0
After after A Af Aft Afte r er ter fter BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 3 5 0
randomization randomization r ra ran rand n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 5 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
were were w we wer were e re ere were BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
treated treated t tr tre trea d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
six six s si six six x ix six six BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
weeks weeks w we wee week s ks eks eeks BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 3 5 0
single single s si sin sing e le gle ngle BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
daily daily d da dai dail y ly ily aily BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
dose dose d do dos dose e se ose dose BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 5 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
either either e ei eit eith r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 3 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 6 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
or or o or or or r or or or BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 3 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 6 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 3 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 6 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 6 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
80 80 8 80 80 80 0 80 80 80 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 3 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 3 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 3 6 0
pravastatin pravastatin p pr pra prav n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 3 6 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 6 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 6 0
or or o or or or r or or or BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 6 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 6 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
80 80 8 80 80 80 0 80 80 80 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 6 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 4 6 0
the the t th the the e he the the BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
size size s si siz size e ze ize size BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
each each e ea eac each h ch ach each BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
treatment treatment t tr tre trea t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
group group g gr gro grou p up oup roup BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
ranged ranged r ra ran rang d ed ged nged BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
from from f fr fro from m om rom from BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
156 156 1 15 156 156 6 56 156 156 BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 6 0
167 167 1 16 167 167 7 67 167 167 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 4 6 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 4 6 0
At at A At At At t At At At BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 6 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 6 0
rosuvas rosuvas r ro ros rosu s as vas uvas BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 6 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 6 0
tatin tatin t ta tat tati n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
reduced reduced r re red redu d ed ced uced BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 4 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 7 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 7 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
46% 46% 4 46 46% 46% % 6% 46% 46% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 7 0
sig sig s si sig sig g ig sig sig BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 7 0
nificantly nificantly n ni nif nifi y ly tly ntly BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
more more m mo mor more e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
than than t th tha than n an han than BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 7 0
37% 37% 3 37 37% 37% % 7% 37% 37% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 7 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 7 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 7 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 7 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 7 0
28 28 2 28 28 28 8 28 28 28 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 7 0
39% 39% 3 39 39% 39% % 9% 39% 39% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 7 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 7 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
pravas pravas p pr pra prav s as vas avas BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 7 0
tatin tatin t ta tat tati n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 7 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 7 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
– – – – – – – – – – BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 7 0
30% 30% 3 30 30% 30% % 0% 30% 30% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 7 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 7 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 4 7 0
At at A At At At t At At At BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 7 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
highest highest h hi hig high t st est hest BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
doses doses d do dos dose s es ses oses BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 7 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 7 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
reduced reduced r re red redu d ed ced uced BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 4 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 7 0
C c C C C C C C C C BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 7 0
levels levels l le lev leve s ls els vels BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
55% 55% 5 55 55% 55% % 5% 55% 55% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 7 0
compared compared c co com comp d ed red ared BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
51% 51% 5 51 51% 51% % 1% 51% 51% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 7 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 7 0
80 80 8 80 80 80 0 80 80 80 BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 8 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
46% 46% 4 46 46% 46% % 6% 46% 46% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 4 8 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
80 80 8 80 80 80 0 80 80 80 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 4 8 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 4 8 0
Indications indications I In Ind Indi s ns ons ions BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 4 8 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 4 8 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
indicated indicated i in ind indi d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
an an a an an an n an an an BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
adjunct adjunct a ad adj adju t ct nct unct BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
to to t to to to o to to to BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
diet diet d di die diet t et iet diet BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
reduce reduce r re red redu e ce uce duce BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
elevated elevated e el ele elev d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
total total t to tot tota l al tal otal BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 8 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 8 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 8 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 4 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 8 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 8 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 8 0
Apo apo A Ap Apo Apo o po Apo Apo BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 8 0
B b B B B B B B B B BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 8 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 8 0
non non n no non non n on non non BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 8 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 4 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 8 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 8 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
triglyceride triglyceride t tr tri trig e de ide ride BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 8 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
to to t to to to o to to to BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 8 0
increase increase i in inc incr e se ase ease BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 4 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 9 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 4 9 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
with with w wi wit with h th ith with BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
primary primary p pr pri prim y ry ary mary BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
hypercholesterolaemia hypercholesterolaemia h hy hyp hype a ia mia emia BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 9 0
heterozygous heterozygous h he het hete s us ous gous BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
familial familial f fa fam fami l al ial lial BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
non non n no non non n on non non BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 9 0
familial familial f fa fam fami l al ial lial BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 9 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
mixed mixed m mi mix mixe d ed xed ixed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
dyslipi dyslipi d dy dys dysl i pi ipi lipi BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 9 0
daemia daemia d da dae daem a ia mia emia BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 4 9 0
Frederickson frederickson F Fr Fre Fred n on son kson BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 9 0
type type t ty typ type e pe ype type BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
IIa iia I II IIa IIa a Ia IIa IIa BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 9 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
IIb iib I II IIb IIb b Ib IIb IIb BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 9 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 4 9 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 4 9 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 4 9 0
On on O On On On n On On On BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 4 9 0
the the t th the the e he the the BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
basis basis b ba bas basi s is sis asis BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
of of o of of of f of of of BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
small small s sm sma smal l ll all mall BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
- - - - - - - - - - BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 9 0
scale scale s sc sca scal e le ale cale BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
trials trials t tr tri tria s ls als ials BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
, , , , , , , , , , BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 4 9 0
rosuvas rosuvas r ro ros rosu s as vas uvas BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
- - - - - - - - - - BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 4 9 0
tatin tatin t ta tat tati n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
also also a al als also o so lso also BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
indicated indicated i in ind indi d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
an an a an an an n an an an BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
adjunct adjunct a ad adj adju t ct nct unct BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
to to t to to to o to to to BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 9 0
diet diet d di die diet t et iet diet BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 10 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 4 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
treatment treatment t tr tre trea t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
elevated elevated e el ele elev d ed ted ated BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
serum serum s se ser seru m um rum erum BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
triglyceride triglyceride t tr tri trig e de ide ride BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 10 0
Frederickson frederickson F Fr Fre Fred n on son kson BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
type type t ty typ type e pe ype type BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
IV iv I IV IV IV V IV IV IV BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 10 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
reduce reduce r re red redu e ce uce duce BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 5 10 0
total total t to tot tota l al tal otal BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
Apo apo A Ap Apo Apo o po Apo Apo BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
B b B B B B B B B B BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
homozygous homozygous h ho hom homo s us ous gous BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
familial familial f fa fam fami l al ial lial BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
hypercholesterolaemia hypercholesterolaemia h hy hyp hype a ia mia emia BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
an an a an an an n an an an BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
adjunct adjunct a ad adj adju t ct nct unct BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
other other o ot oth othe r er her ther BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
lipid lipid l li lip lipi d id pid ipid BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
treatments treatments t tr tre trea s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
if if i if if if f if if if BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
such such s su suc such h ch uch such BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
treatments treatments t tr tre trea s ts nts ents BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
are are a ar are are e re are are BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 11 0
unavailable unavailable u un una unav e le ble able BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 11 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 11 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 5 11 0
▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ ▲ BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 11 0
N n N N N N N N N N BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
N n N N N N N N N N BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
F f F F F F F F F F BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 8 0
N n N N N N N N N N BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
CH ch C CH CH CH H CH CH CH BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
S s S S S S S S S S BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
H h H H H H H H H H BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
C c C C C C C C C C BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
OH oh O OH OH OH H OH OH OH BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 9 0
OH oh O OH OH OH H OH OH OH BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 9 0
Ca ca C Ca Ca Ca a Ca Ca Ca BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 9 0
2+ 2+ 2 2+ 2+ 2+ + 2+ 2+ 2+ BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 5 9 0
O o O O O O O O O O BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
b b b b b b b b b b BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 1 0 NOCAPS NODIGIT 1 NOPUNCT 5 9 0
OH oh O OH OH OH H OH OH OH BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
OH oh O OH OH OH H OH OH OH BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
OH oh O OH OH OH H OH OH OH BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
O o O O O O O O O O BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
S s S S S S S S S S BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
reductase reductase r re red redu e se ase tase BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKIN LINESTART ALIGNEDLEFT NEWFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
O o O O O O O O O O BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
Mevalonate mevalonate M Me Mev Meva e te ate nate BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
2 2 2 2 2 2 2 2 2 2 BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
– – – – – – – – – – BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
– – – – – – – – – – BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
– – – – – – – – – – BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 5 8 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 5 8 0
Bis bis B Bi Bis Bis s is Bis Bis BLOCKIN LINESTART ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 8 0
[ [ [ [ [ [ [ [ [ [ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 8 0
E e E E E E E E E E BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 8 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
7 7 7 7 7 7 7 7 7 7 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
[ [ [ [ [ [ [ [ [ [ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 8 0
4 4 4 4 4 4 4 4 4 4 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 8 0
4 4 4 4 4 4 4 4 4 4 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
fluorophenyl fluorophenyl f fl flu fluo l yl nyl enyl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 8 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 8 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
isopropyl isopropyl i is iso isop l yl pyl opyl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 8 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 8 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
[ [ [ [ [ [ [ [ [ [ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 9 0
methyl methyl m me met meth l yl hyl thyl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 9 0
methylsulphonyl methylsulphonyl m me met meth l yl nyl onyl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 9 0
amino amino a am ami amin o no ino mino BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
] ] ] ] ] ] ] ] ] ] BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 9 0
pyrimidin pyrimidin p py pyr pyri n in din idin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
yl yl y yl yl yl l yl yl yl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
] ] ] ] ] ] ] ] ] ] BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 9 0
3R 3r 3 3R 3R 3R R 3R 3R 3R BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 5 9 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 5 9 0
5S 5s 5 5S 5S 5S S 5S 5S 5S BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 5 9 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 5 9 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
dihydroxyhept dihydroxyhept d di dih dihy t pt ept hept BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
enoic enoic e en eno enoi c ic oic noic BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
acid acid a ac aci acid d id cid acid BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
] ] ] ] ] ] ] ] ] ] BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 9 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
salt salt s sa sal salt t lt alt salt BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 5 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 5 9 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
22 22 2 22 22 22 2 22 22 22 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 5 9 0
H h H H H H H H H H BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
27 27 2 27 27 27 7 27 27 27 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 5 9 0
FN fn F FN FN FN N FN FN FN BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
O o O O O O O O O O BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
S s S S S S S S S S BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 5 9 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
Ca ca C Ca Ca Ca a Ca Ca Ca BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 5 9 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 5 9 0
M m M M M M M M M M BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
r r r r r r r r r r BLOCKIN LINEIN ALIGNEDLEFT NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 1 NOPUNCT 5 9 0
= = = = = = = = = = BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 9 0
1001 1001 1 10 100 1001 1 01 001 1001 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 5 9 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 5 9 0
14 14 1 14 14 14 4 14 14 14 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 5 9 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 5 9 0
CAS cas C CA CAS CAS S AS CAS CAS BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 5 9 0
registry registry r re reg regi y ry try stry BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
number number n nu num numb r er ber mber BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 9 0
: : : : : : : : : : BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 5 9 0
147098 147098 1 14 147 1470 8 98 098 7098 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 5 9 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 9 0
2 2 2 2 2 2 2 2 2 2 BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 9 0
a a a a a a a a a a BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 1 0 NOCAPS NODIGIT 1 NOPUNCT 5 8 0
Figure figure F Fi Fig Figu e re ure gure BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
1 1 1 1 1 1 1 1 1 1 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 10 0
| | | | | | | | | | BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
calcium calcium c ca cal calc m um ium cium BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 DOT 5 10 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 NOPUNCT 5 10 0
| | | | | | | | | | BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 5 10 0
The the T Th The The e he The The BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
molecule molecule m mo mol mole e le ule cule BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
contains contains c co con cont s ns ins ains BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
characteristic characteristic c ch cha char c ic tic stic BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
statin statin s st sta stat n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
pharmacophore pharmacophore p ph pha phar e re ore hore BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 5 10 0
a a a a a a a a a a BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 5 10 0
dihydroxy dihydroxy d di dih dihy y xy oxy roxy BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
heptenoic heptenoic h he hep hept c ic oic noic BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
acid acid a ac aci acid d id cid acid BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
moiety moiety m mo moi moie y ty ety iety BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
that that t th tha that t at hat that BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
binds binds b bi bin bind s ds nds inds BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
active active a ac act acti e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
site site s si sit site e te ite site BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
hydroxy hydroxy h hy hyd hydr y xy oxy roxy BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 5 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 5 10 0
methylglutaryl methylglutaryl m me met meth l yl ryl aryl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 5 10 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 5 10 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 OPENBRACKET 6 10 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 NOPUNCT 6 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 HYPHEN 6 10 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 NOPUNCT 6 10 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 ENDBRACKET 6 10 0
reductase reductase r re red redu e se ase tase BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 6 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
structures structures s st str stru s es res ures BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
substrate substrate s su sub subs e te ate rate BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
product product p pr pro prod t ct uct duct BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
reaction reaction r re rea reac n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
catalysed catalysed c ca cat cata d ed sed ysed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
HMG hmg H HM HMG HMG G MG HMG HMG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 6 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 6 10 0
CoA coa C Co CoA CoA A oA CoA CoA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 6 10 0
reductase reductase r re red redu e se ase tase BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
are are a ar are are e re are are BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
shown shown s sh sho show n wn own hown BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
b b b b b b b b b b BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 NOPUNCT 6 10 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
comparison comparison c co com comp n on son ison BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 6 10 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 10 0
The the T Th The The e he The The BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 6 10 0
remainder remainder r re rem rema r er der nder BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
molecule molecule m mo mol mole e le ule cule BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 6 10 0
which which w wh whi whic h ch ich hich BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
structurally structurally s st str stru y ly lly ally BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
distinct distinct d di dis dist t ct nct inct BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
from from f fr fro from m om rom from BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
corres corres c co cor corr s es res rres BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 10 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 6 10 0
ponding ponding p po pon pond g ng ing ding BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
portions portions p po por port s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
other other o ot oth othe r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 6 11 0
contains contains c co con cont s ns ins ains BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 6 11 0
polar polar p po pol pola r ar lar olar BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
sulphonyl sulphonyl s su sul sulp l yl nyl onyl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
moiety moiety m mo moi moie y ty ety iety BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
that that t th tha that t at hat that BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
confers confers c co con conf s rs ers fers BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
relatively relatively r re rel rela y ly ely vely BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
low low l lo low low w ow low low BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
lipophilicity lipophilicity l li lip lipo y ty ity city BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 11 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 11 0
The the T Th The The e he The The BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 6 1 0
market market m ma mar mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 6 1 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
drugs drugs d dr dru drug s gs ugs rugs BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
is is i is is is s is is is BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
largest largest l la lar larg t st est gest BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
pharmaceutical pharmaceutical p ph pha phar l al cal ical BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
sector sector s se sec sect r or tor ctor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 1 0
Driven driven D Dr Dri Driv n en ven iven BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 6 1 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 6 1 0
prevalent prevalent p pr pre prev t nt ent lent BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
patient patient p pa pat pati t nt ent ient BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
population population p po pop popu n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
in in i in in in n in in in BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
excess excess e ex exc exce s ss ess cess BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
295 295 2 29 295 295 5 95 295 295 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 6 1 0
million million m mi mil mill n on ion lion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
valued valued v va val valu d ed ued lued BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
at at a at at at t at at at BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
more more m mo mor more e re ore more BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 1 0
than than t th tha than n an han than BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 6 2 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 6 2 0
17 17 1 17 17 17 7 17 17 17 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 6 2 0
billion billion b bi bil bill n on ion lion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 6 2 0
this this t th thi this s is his this BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
market market m ma mar mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
dominated dominated d do dom domi d ed ted ated BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
by by b by by by y by by by BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 OPENBRACKET 6 2 0
FIG fig F FI FIG FIG G IG FIG FIG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 6 2 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 2 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 6 2 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 6 2 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 2 0
Competition competition C Co Com Comp n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 6 2 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
this this t th thi this s is his this BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
crowded crowded c cr cro crow d ed ded wded BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
segment segment s se seg segm t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
fierce fierce f fi fie fier e ce rce erce BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 6 2 0
but but b bu but but t ut but but BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
rewards rewards r re rew rewa s ds rds ards BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
for for f fo for for r or for for BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
successful successful s su suc succ l ul ful sful BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
market market m ma mar mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
entry entry e en ent entr y ry try ntry BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
substantial substantial s su sub subs l al ial tial BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 2 0
In in I In In In n In In In BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 6 2 0
2002 2002 2 20 200 2002 2 02 002 2002 BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 6 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 6 2 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
recorded recorded r re rec reco d ed ded rded BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
revenues revenues r re rev reve s es ues nues BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
treatment treatment t tr tre trea t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
dyslipidaemia dyslipidaemia d dy dys dysl a ia mia emia BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
in in i in in in n in in in BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 2 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
seven seven s se sev seve n en ven even BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
major major m ma maj majo r or jor ajor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
markets markets m ma mar mark s ts ets kets BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
~US ~us ~ ~U ~US ~US S US ~US ~US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 6 3 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 6 3 0
7 7 7 7 7 7 7 7 7 7 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 6 3 0
billion billion b bi bil bill n on ion lion BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
and and a an and and d nd and and BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
~US ~us ~ ~U ~US ~US S US ~US ~US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 6 3 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 6 3 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 6 3 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 3 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 6 3 0
billion billion b bi bil bill n on ion lion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 6 3 0
respectively respectively r re res resp y ly ely vely BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 OPENBRACKET 6 3 0
FIG fig F FI FIG FIG G IG FIG FIG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 6 3 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 3 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 6 3 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 6 3 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 6 3 0
New new N Ne New New w ew New New BLOCKIN LINESTART LINEINDENT SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 6 3 0
entrants entrants e en ent entr s ts nts ants BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
in in i in in in n in in in BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
the the t th the the e he the the BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
dyslipidaemia dyslipidaemia d dy dys dysl a ia mia emia BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
market market m ma mar mark t et ket rket BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
face face f fa fac face e ce ace face BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 6 3 0
considerable considerable c co con cons e le ble able BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
barriers barriers b ba bar barr s rs ers iers BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
success success s su suc succ s ss ess cess BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 7 3 0
Prescrip prescrip P Pr Pre Pres p ip rip crip BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 3 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 7 3 0
tions tions t ti tio tion s ns ons ions BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
most most m mo mos most t st ost most BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
potent potent p po pot pote t nt ent tent BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
established established e es est esta d ed hed shed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 3 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
both both b bo bot both h th oth both BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 3 0
supported supported s su sup supp d ed ted rted BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
compelling compelling c co com comp g ng ing ling BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
long long l lo lon long g ng ong long BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 7 4 0
term term t te ter term m rm erm term BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
safety safety s sa saf safe y ty ety fety BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
mortality mortality m mo mor mort y ty ity lity BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
data data d da dat data a ta ata data BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 7 4 0
Moreover moreover M Mo Mor More r er ver over BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 4 0
generic generic g ge gen gene c ic ric eric BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
will will w wi wil will l ll ill will BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
soon soon s so soo soon n on oon soon BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
be be b be be be e be be be BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
available available a av ava avai e le ble able BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
many many m ma man many y ny any many BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
markets markets m ma mar mark s ts ets kets BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 7 4 0
including including i in inc incl g ng ing ding BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
massive massive m ma mas mass e ve ive sive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 4 0
market market m ma mar mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 7 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 4 0
promoting promoting p pr pro prom g ng ing ting BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
its its i it its its s ts its its BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
greater greater g gr gre grea r er ter ater BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
use use u us use use e se use use BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
primary primary p pr pri prim y ry ary mary BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
prevention prevention p pr pre prev n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 4 0
CHD chd C CH CHD CHD D HD CHD CHD BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 4 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 7 4 0
We we W We We We e We We We BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
predict predict p pr pre pred t ct ict dict BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
that that t th tha that t at hat that BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
the the t th the the e he the the BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
dyslipidaemia dyslipidaemia d dy dys dysl a ia mia emia BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
market market m ma mar mark t et ket rket BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
will will w wi wil will l ll ill will BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
grow grow g gr gro grow w ow row grow BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 5 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 7 5 0
32 32 3 32 32 32 2 32 32 32 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 7 5 0
billion billion b bi bil bill n on ion lion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
2012 2012 2 20 201 2012 2 12 012 2012 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 7 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 OPENBRACKET 7 5 0
FIG fig F FI FIG FIG G IG FIG FIG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 7 5 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 7 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 7 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 7 5 0
The the T Th The The e he The The BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
adoption adoption a ad ado adop n on ion tion BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
' ' ' ' ' ' ' ' ' ' BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 QUOTE 7 5 0
lower lower l lo low lowe r er wer ower BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
better better b be bet bett r er ter tter BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
' ' ' ' ' ' ' ' ' ' BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 QUOTE 7 5 0
treatment treatment t tr tre trea t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
goals goals g go goa goal s ls als oals BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
for for f fo for for r or for for BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 7 5 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 7 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 5 0
together together t to tog toge r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
recommendations recommendations r re rec reco s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
4 4 4 4 4 4 4 4 4 4 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 7 5 0
from from f fr fro from m om rom from BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 5 0
National national N Na Nat Nati l al nal onal BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
Cholesterol cholesterol C Ch Cho Chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
Education education E Ed Edu Educ n on ion tion BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
Program program P Pr Pro Prog m am ram gram BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
Adult adult A Ad Adu Adul t lt ult dult BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
Treatment treatment T Tr Tre Trea t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
Panel panel P Pa Pan Pane l el nel anel BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 5 0
III iii I II III III I II III III BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 7 5 0
encourag encourag e en enc enco g ag rag urag BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 5 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 7 5 0
ing ing i in ing ing g ng ing ing BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
more more m mo mor more e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
aggressive aggressive a ag agg aggr e ve ive sive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
prescription prescription p pr pre pres n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
lipid lipid l li lip lipi d id pid ipid BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 7 6 0
modifying modifying m mo mod modi g ng ing ying BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
therapies therapies t th the ther s es ies pies BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 6 0
will will w wi wil will l ll ill will BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
favour favour f fa fav favo r ur our vour BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
use use u us use use e se use use BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
potent potent p po pot pote t nt ent tent BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 7 6 0
If if I If If If f If If If BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 7 6 0
emerging emerging e em eme emer g ng ing ging BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
agents agents a ag age agen s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
such such s su suc such h ch uch such BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
rosu rosu r ro ros rosu u su osu rosu BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 7 6 0
vastatin vastatin v va vas vast n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
succeed succeed s su suc succ d ed eed ceed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
this this t th thi this s is his this BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
market market m ma mar mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 6 0
they they t th the they y ey hey they BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
must must m mu mus must t st ust must BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
offer offer o of off offe r er fer ffer BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
improved improved i im imp impr d ed ved oved BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
efficacy efficacy e ef eff effi y cy acy cacy BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 6 0
morbidity morbidity m mo mor morb y ty ity dity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
mortality mortality m mo mor mort y ty ity lity BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
benefits benefits b be ben bene s ts its fits BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
relative relative r re rel rela e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
established established e es est esta d ed hed shed BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 6 0
agents agents a ag age agen s ts nts ents BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 7 7 0
without without w wi wit with t ut out hout BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 7 0
compromising compromising c co com comp g ng ing sing BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 7 7 0
patient patient p pa pat pati t nt ent ient BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
safety safety s sa saf safe y ty ety fety BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 8 7 0
Impact impact I Im Imp Impa t ct act pact BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 NOPUNCT 8 7 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
Dose dose D Do Dos Dose e se ose Dose BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 8 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 7 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 7 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 7 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
more more m mo mor more e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
effective effective e ef eff effe e ve ive tive BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
in in i in in in n in in in BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
lowering lowering l lo low lowe g ng ing ring BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 8 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 7 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 8 7 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
raising raising r ra rai rais g ng ing sing BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 7 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 8 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 7 0
C c C C C C C C C C BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 8 7 0
levels levels l le lev leve s ls els vels BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
than than t th tha than n an han than BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 1 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
or or o or or or r or or or BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
pravastatin pravastatin p pr pra prav n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
7 7 7 7 7 7 7 7 7 7 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 8 1 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 8 1 0
Furthermore furthermore F Fu Fur Furt e re ore more BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 8 1 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 1 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
is is i is is is s is is is BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
reported reported r re rep repo d ed ted rted BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
have have h ha hav have e ve ave have BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 8 1 0
side side s si sid side e de ide side BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 1 0
effect effect e ef eff effe t ct ect fect BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
profile profile p pr pro prof e le ile file BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
similar similar s si sim simi r ar lar ilar BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
to to t to to to o to to to BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
its its i it its its s ts its its BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
competitors competitors c co com comp s rs ors tors BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 8 1 0
Ultimately ultimately U Ul Ult Ulti y ly ely tely BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 8 1 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 1 0
this this t th thi this s is his this BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
greater greater g gr gre grea r er ter ater BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 1 0
efficacy efficacy e ef eff effi y cy acy cacy BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
should should s sh sho shou d ld uld ould BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
drive drive d dr dri driv e ve ive rive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
widespread widespread w wi wid wide d ad ead read BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
use use u us use use e se use use BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 8 2 0
However however H Ho How Howe r er ver ever BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 8 2 0
, , , , , , , , , , BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 2 0
the the t th the the e he the the BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
withdrawal withdrawal w wi wit with l al wal awal BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
of of o of of of f of of of BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
cerivastatin cerivastatin c ce cer ceri n in tin atin BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
and and a an and and d nd and and BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
concerns concerns c co con conc s ns rns erns BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 8 2 0
FDA fda F FD FDA FDA A DA FDA FDA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 8 2 0
about about a ab abo abou t ut out bout BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
rhab rhab r rh rha rhab b ab hab rhab BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 2 0
domyolysis domyolysis d do dom domy s is sis ysis BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
associated associated a as ass asso d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
statin statin s st sta stat n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
treatment treatment t tr tre trea t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 2 0
in in i in in in n in in in BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
particular particular p pa par part r ar lar ular BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
high high h hi hig high h gh igh high BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
doses doses d do dos dose s es ses oses BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 2 0
culminated culminated c cu cul culm d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
in in i in in in n in in in BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 2 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
voluntary voluntary v vo vol volu y ry ary tary BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
withdrawal withdrawal w wi wit with l al wal awal BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
AstraZeneca astrazeneca A As Ast Astr a ca eca neca BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 8 3 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
NDA nda N ND NDA NDA A DA NDA NDA BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 8 3 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
80 80 8 80 80 80 0 80 80 80 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 8 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 3 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
a a a a a a a a a a BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 8 3 0
request request r re req requ t st est uest BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
further further f fu fur furt r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
data data d da dat data a ta ata data BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
supporting supporting s su sup supp g ng ing ting BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
the the t th the the e he the the BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
safety safety s sa saf safe y ty ety fety BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
other other o ot oth othe r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
doses doses d do dos dose s es ses oses BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 8 3 0
In in I In In In n In In In BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 8 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
light light l li lig ligh t ht ght ight BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
these these t th the thes e se ese hese BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
con con c co con con n on con con BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 3 0
cerns cerns c ce cer cern s ns rns erns BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 8 3 0
considerations considerations c co con cons s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
about about a ab abo abou t ut out bout BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
relevance relevance r re rel rele e ce nce ance BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
proteinurea proteinurea p pr pro prot a ea rea urea BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
associated associated a as ass asso d ed ted ated BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 8 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 8 3 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
dose dose d do dos dose e se ose dose BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 3 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 8 4 0
included included i in inc incl d ed ded uded BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 8 4 0
warning warning w wa war warn g ng ing ning BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
on on o on on on n on on on BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
the the t th the the e he the the BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
label label l la lab labe l el bel abel BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 8 4 0
could could c co cou coul d ld uld ould BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
temper temper t te tem temp r er per mper BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
success success s su suc succ s ss ess cess BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
this this t th thi this s is his this BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
agent agent a ag age agen t nt ent gent BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 8 4 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 8 4 0
Until until U Un Unt Unti l il til ntil BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 4 0
positive positive p po pos posi e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
long long l lo lon long g ng ong long BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 4 0
term term t te ter term m rm erm term BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
safety safety s sa saf safe y ty ety fety BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
mortality mortality m mo mor mort y ty ity lity BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
data data d da dat data a ta ata data BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
available available a av ava avai e le ble able BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 4 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
expected expected e ex exp expe d ed ted cted BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
to to t to to to o to to to BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
be be b be be be e be be be BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
restricted restricted r re res rest d ed ted cted BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
high high h hi hig high h gh igh high BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 4 0
risk risk r ri ris risk k sk isk risk BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 4 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
those those t th tho thos e se ose hose BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 4 0
unable unable u un una unab e le ble able BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
achieve achieve a ac ach achi e ve eve ieve BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
target target t ta tar targ t et get rget BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
lipid lipid l li lip lipi d id pid ipid BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
levels levels l le lev leve s ls els vels BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
with with w wi wit with h th ith with BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
other other o ot oth othe r er her ther BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
treatments treatments t tr tre trea s ts nts ents BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 9 5 0
nevertheless nevertheless n ne nev neve s ss ess less BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 5 0
sales sales s sa sal sale s es les ales BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
2007 2007 2 20 200 2007 7 07 007 2007 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 5 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
still still s st sti stil l ll ill till BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
forecast forecast f fo for fore t st ast cast BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
exceed exceed e ex exc exce d ed eed ceed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 9 5 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 9 5 0
1 1 1 1 1 1 1 1 1 1 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 9 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 5 0
7 7 7 7 7 7 7 7 7 7 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 9 5 0
billion billion b bi bil bill n on ion lion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 OPENBRACKET 9 5 0
FIG fig F FI FIG FIG G IG FIG FIG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 9 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 5 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 9 5 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 9 5 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 5 0
AstraZeneca astrazeneca A As Ast Astr a ca eca neca BLOCKIN LINESTART LINEINDENT SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 9 5 0
' ' ' ' ' ' ' ' ' ' BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 QUOTE 9 5 0
s s s s s s s s s s BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 9 5 0
pricing pricing p pr pri pric g ng ing cing BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
policy policy p po pol poli y cy icy licy BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
will will w wi wil will l ll ill will BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
promote promote p pr pro prom e te ote mote BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
use use u us use use e se use use BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
severely severely s se sev seve y ly ely rely BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
affected affected a af aff affe d ed ted cted BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
patients patients p pa pat pati s ts nts ents BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 5 0
In in I In In In n In In In BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 5 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
United united U Un Uni Unit d ed ted ited BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 5 0
States states S St Sta Stat s es tes ates BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 5 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
is is i is is is s is is is BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 5 0
flat flat f fl fla flat t at lat flat BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
priced priced p pr pri pric d ed ced iced BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
at at a at at at t at at at BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 9 6 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 9 6 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 9 6 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 6 0
per per p pe per per r er per per BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 6 0
making making m ma mak maki g ng ing king BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
it it i it it it t it it it BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
more more m mo mor more e re ore more BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
expensive expensive e ex exp expe e ve ive sive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
than than t th tha than n an han than BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
10 10 1 10 10 10 0 10 10 10 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
dose dose d do dos dose e se ose dose BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
ator ator a at ato ator r or tor ator BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
vastatin vastatin v va vas vast n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 6 0
but but b bu but but t ut but but BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
substantially substantially s su sub subs y ly lly ally BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
less less l le les less s ss ess less BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
expensive expensive e ex exp expe e ve ive sive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
than than t th tha than n an han than BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
20 20 2 20 20 20 0 20 20 20 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 6 0
40 40 4 40 40 40 0 40 40 40 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
or or o or or or r or or or BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
80 80 8 80 80 80 0 80 80 80 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
mg mg m mg mg mg g mg mg mg BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
doses doses d do dos dose s es ses oses BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 6 0
In in I In In In n In In In BLOCKIN LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 6 0
moderately moderately m mo mod mode y ly ely tely BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
affected affected a af aff affe d ed ted cted BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
or or o or or or r or or or BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
normo normo n no nor norm o mo rmo ormo BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
choles choles c ch cho chol s es les oles BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
- - - - - - - - - - BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 6 0
terolaemic terolaemic t te ter tero c ic mic emic BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
people people p pe peo peop e le ple ople BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 6 0
strong strong s st str stro g ng ong rong BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
support support s su sup supp t rt ort port BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
use use u us use use e se use use BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 6 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
could could c co cou coul d ld uld ould BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
be be b be be be e be be be BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
provided provided p pr pro prov d ed ded ided BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
data data d da dat data a ta ata data BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
from from f fr fro from m om rom from BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
15 15 1 15 15 15 5 15 15 15 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 7 0
000 000 0 00 000 000 0 00 000 000 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 7 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 9 7 0
patient patient p pa pat pati t nt ent ient BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
JUPITER jupiter J JU JUP JUPI R ER TER ITER BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 9 7 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 9 7 0
Justification justification J Ju Jus Just n on ion tion BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
for for f fo for for r or for for BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
Use use U Us Use Use e se Use Use BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
statins statins s st sta stat s ns ins tins BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
Primary primary P Pr Pri Prim y ry ary mary BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
prevention prevention p pr pre prev n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
: : : : : : : : : : BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 9 7 0
an an a an an an n an an an BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
Intervention intervention I In Int Inte n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
Trial trial T Tr Tri Tria l al ial rial BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
Evaluating evaluating E Ev Eva Eval g ng ing ting BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 7 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 9 7 0
study study s st stu stud y dy udy tudy BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 7 0
which which w wh whi whic h ch ich hich BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
is is i is is is s is is is BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
expected expected e ex exp expe d ed ted cted BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
report report r re rep repo t rt ort port BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 9 7 0
2006 2006 2 20 200 2006 6 06 006 2006 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 9 7 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 9 7 0
Additionally additionally A Ad Add Addi y ly lly ally BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 9 1 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 9 1 0
this this t th thi this s is his this BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
study study s st stu stud y dy udy tudy BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
will will w wi wil will l ll ill will BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
examine examine e ex exa exam e ne ine mine BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
effect effect e ef eff effe t ct ect fect BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
of of o of of of f of of of BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
on on o on on on n on on on BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
emerging emerging e em eme emer g ng ing ging BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
cardiovascular cardiovascular c ca car card r ar lar ular BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
risk risk r ri ris risk k sk isk risk BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
factors factors f fa fac fact s rs ors tors BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
such such s su suc such h ch uch such BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
inflammatory inflammatory i in inf infl y ry ory tory BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
marker marker m ma mar mark r er ker rker BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
C c C C C C C C C C BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 10 1 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 10 1 0
reactive reactive r re rea reac e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
protein protein p pr pro prot n in ein tein BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 10 1 0
CRP crp C CR CRP CRP P RP CRP CRP BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 10 1 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 10 1 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 1 0
Assuming assuming A As Ass Assu g ng ing ming BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 1 0
that that t th tha that t at hat that BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
the the t th the the e he the the BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 1 0
results results r re res resu s ts lts ults BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
from from f fr fro from m om rom from BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
this this t th thi this s is his this BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
other other o ot oth othe r er her ther BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
trials trials t tr tri tria s ls als ials BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
positive positive p po pos posi e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 10 2 0
sales sales s sa sal sale s es les ales BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
could could c co cou coul d ld uld ould BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
grow grow g gr gro grow w ow row grow BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 10 2 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 10 2 0
4 4 4 4 4 4 4 4 4 4 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 10 2 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 2 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 10 2 0
billion billion b bi bil bill n on ion lion BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
2012 2012 2 20 201 2012 2 12 012 2012 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 NOPUNCT 10 2 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 OPENBRACKET 10 2 0
FIG fig F FI FIG FIG G IG FIG FIG BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 10 2 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 2 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 10 2 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 10 2 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 2 0
The the T Th The The e he The The BLOCKIN LINESTART LINEINDENT SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 NOPUNCT 10 2 0
main main m ma mai main n in ain main BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
threats threats t th thr thre s ts ats eats BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
to to t to to to o to to to BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
rosuvastatin rosuvastatin r ro ros rosu n in tin atin BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
' ' ' ' ' ' ' ' ' ' BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 QUOTE 10 2 0
s s s s s s s s s s BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 10 2 0
success success s su suc succ s ss ess cess BLOCKIN LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
will will w wi wil will l ll ill will BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
be be b be be be e be be be BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
atorvastatin atorvastatin a at ato ator n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
com com c co com com m om com com BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 10 2 0
bination bination b bi bin bina n on ion tion BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
therapies therapies t th the ther s es ies pies BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
development development d de dev deve t nt ent ment BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
by by b by by by y by by by BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 2 0
Merck merck M Me Mer Merc k ck rck erck BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 2 0
and and a an and and d nd and and BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
Pfizer pfizer P Pf Pfi Pfiz r er zer izer BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 10 3 0
respectively respectively r re res resp y ly ely vely BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 3 0
Merck merck M Me Mer Merc k ck rck erck BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
developing developing d de dev deve g ng ing ping BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
a a a a a a a a a a BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 10 3 0
fixed fixed f fi fix fixe d ed xed ixed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
pill pill p pi pil pill l ll ill pill BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
combination combination c co com comb n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
simvastatin simvastatin s si sim simv n in tin atin BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
and and a an and and d nd and and BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
the the t th the the e he the the BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
cholesterol cholesterol c ch cho chol l ol rol erol BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
absorption absorption a ab abs abso n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
inhibitor inhibitor i in inh inhi r or tor itor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
ezetimibe ezetimibe e ez eze ezet e be ibe mibe BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 10 3 0
Zetia zetia Z Ze Zet Zeti a ia tia etia BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
; ; ; ; ; ; ; ; ; ; BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 PUNCT 10 3 0
Schering schering S Sc Sch Sche g ng ing ring BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 10 3 0
Plough plough P Pl Plo Plou h gh ugh ough BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
/ / / / / / / / / / BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 10 3 0
Merck merck M Me Mer Merc k ck rck erck BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 10 3 0
8 8 8 8 8 8 8 8 8 8 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 10 3 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 DOT 10 3 0
Pfizer pfizer P Pf Pfi Pfiz r er zer izer BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 3 0
are are a ar are are e re are are BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
developing developing d de dev deve g ng ing ping BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
a a a a a a a a a a BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 NOPUNCT 10 3 0
fixed fixed f fi fix fixe d ed xed ixed BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
pill pill p pi pil pill l ll ill pill BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
combination combination c co com comb n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
ator ator a at ato ator r or tor ator BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
- - - - - - - - - - BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 10 3 0
vastatin vastatin v va vas vast n in tin atin BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
cholesteryl cholesteryl c ch cho chol l yl ryl eryl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
ester ester e es est este r er ter ster BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
transferase transferase t tr tra tran e se ase rase BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 3 0
protein protein p pr pro prot n in ein tein BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 10 4 0
CETP cetp C CE CET CETP P TP ETP CETP BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 10 4 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 10 4 0
inhibitor inhibitor i in inh inhi r or tor itor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
torcetrapib torcetrapib t to tor torc b ib pib apib BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 4 0
Both both B Bo Bot Both h th oth Both BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 4 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
these these t th the thes e se ese hese BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
combinations combinations c co com comb s ns ons ions BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
offer offer o of off offe r er fer ffer BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
improved improved i im imp impr d ed ved oved BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 10 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 10 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 10 4 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 10 4 0
triglyceride triglyceride t tr tri trig e de ide ride BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 10 4 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 10 4 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 10 4 0
modifying modifying m mo mod modi g ng ing ying BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
efficacy efficacy e ef eff effi y cy acy cacy BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
relative relative r re rel rela e ve ive tive BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
their their t th the thei r ir eir heir BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
respective respective r re res resp e ve ive tive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
monotherapies monotherapies m mo mon mono s es ies pies BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
. . . . . . . . . . BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 10 4 0
Ultimately ultimately U Ul Ult Ulti y ly ely tely BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 10 4 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 10 4 0
we we w we we we e we we we BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
expect expect e ex exp expe t ct ect pect BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
that that t th tha that t at hat that BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
combination combination c co com comb n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 10 4 0
of of o of of of f of of of BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 4 0
price price p pr pri pric e ce ice rice BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 5 0
safety safety s sa saf safe y ty ety fety BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
ability ability a ab abi abil y ty ity lity BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
modify modify m mo mod modi y fy ify dify BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
non non n no non non n on non non BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 11 5 0
LDL ldl L LD LDL LDL L DL LDL LDL BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 11 5 0
lipids lipids l li lip lipi s ds ids pids BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
such such s su suc such h ch uch such BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
HDL hdl H HD HDL HDL L DL HDL HDL BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 11 5 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 11 5 0
C c C C C C C C C C BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 11 5 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
triglycerides triglycerides t tr tri trig s es des ides BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 5 0
as as a as as as s as as as BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
well well w we wel well l ll ell well BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
action action a ac act acti n on ion tion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
of of o of of of f of of of BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
these these t th the thes e se ese hese BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
agents agents a ag age agen s ts nts ents BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
on on o on on on n on on on BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
emerging emerging e em eme emer g ng ing ging BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
risk risk r ri ris risk k sk isk risk BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
factors factors f fa fac fact s rs ors tors BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
such such s su suc such h ch uch such BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
as as a as as as s as as as BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
markers markers m ma mar mark s rs ers kers BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
oxidative oxidative o ox oxi oxid e ve ive tive BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
stress stress s st str stre s ss ess ress BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 5 0
will will w wi wil will l ll ill will BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
prove prove p pr pro prov e ve ove rove BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
decisive decisive d de dec deci e ve ive sive BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
battle battle b ba bat batt e le tle ttle BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
for for f fo for for r or for for BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
market market m ma mar mark t et ket rket BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
dominance dominance d do dom domi e ce nce ance BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 5 0
. . . . . . . . . . BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 5 0
9 9 9 9 9 9 9 9 9 9 BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
29% 29% 2 29 29% 29% % 9% 29% 29% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
3 3 3 3 3 3 3 3 3 3 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 9 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
11% 11% 1 11 11% 11% % 1% 11% 11% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
4 4 4 4 4 4 4 4 4 4 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
14% 14% 1 14 14% 14% % 4% 14% 14% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
9% 9% 9 9% 9% 9% % 9% 9% 9% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
1 1 1 1 1 1 1 1 1 1 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 10 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 10 0
9 9 9 9 9 9 9 9 9 9 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 10 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 10 0
5% 5% 5 5% 5% 5% % 5% 5% 5% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 10 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 10 0
6 6 6 6 6 6 6 6 6 6 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
21% 21% 2 21 21% 21% % 1% 21% 21% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
3 3 3 3 3 3 3 3 3 3 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
4 4 4 4 4 4 4 4 4 4 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
11% 11% 1 11 11% 11% % 1% 11% 11% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
5 5 5 5 5 5 5 5 5 5 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
32% 32% 3 32 32% 32% % 2% 32% 32% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
3 3 3 3 3 3 3 3 3 3 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
6 6 6 6 6 6 6 6 6 6 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
20% 20% 2 20 20% 20% % 0% 20% 20% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
1 1 1 1 1 1 1 1 1 1 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
7% 7% 7 7% 7% 7% % 7% 7% 7% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
7 7 7 7 7 7 7 7 7 7 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
41% 41% 4 41 41% 41% % 1% 41% 41% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
5 5 5 5 5 5 5 5 5 5 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
21% 21% 2 21 21% 21% % 1% 21% 21% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
1 1 1 1 1 1 1 1 1 1 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 9 0
7 7 7 7 7 7 7 7 7 7 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
7% 7% 7 7% 7% 7% % 7% 7% 7% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
2 2 2 2 2 2 2 2 2 2 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 9 0
7 7 7 7 7 7 7 7 7 7 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
9% 9% 9 9% 9% 9% % 9% 9% 9% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
1 1 1 1 1 1 1 1 1 1 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
6% 6% 6 6% 6% 6% % 6% 6% 6% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
3 3 3 3 3 3 3 3 3 3 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
1 1 1 1 1 1 1 1 1 1 BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
13% 13% 1 13 13% 13% % 3% 13% 13% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
1 1 1 1 1 1 1 1 1 1 BLOCKSTART LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 8 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 8 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 8 0
5% 5% 5 5% 5% 5% % 5% 5% 5% BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 8 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 8 0
2007 2007 2 20 200 2007 7 07 007 2007 BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 NOPUNCT 11 9 0
9 9 9 9 9 9 9 9 9 9 BLOCKIN LINESTART LINEINDENT NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
. . . . . . . . . . BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 9 0
5 5 5 5 5 5 5 5 5 5 BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 9 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 9 0
39% 39% 3 39 39% 39% % 9% 39% 39% BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 NOPUNCT 11 9 0
) ) ) ) ) ) ) ) ) ) BLOCKEND LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 9 0
Atorvastatin atorvastatin A At Ato Ator n in tin atin BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
Simvastatin simvastatin S Si Sim Simv n in tin atin BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
Other other O Ot Oth Othe r er her ther BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
statins statins s st sta stat s ns ins tins BLOCKEND LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
Rosuvastatin rosuvastatin R Ro Ros Rosu n in tin atin BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
Other other O Ot Oth Othe r er her ther BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
lipid lipid l li lip lipi d id pid ipid BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
- - - - - - - - - - BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 11 10 0
modifying modifying m mo mod modi g ng ing ying BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
treatments treatments t tr tre trea s ts nts ents BLOCKEND LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
Ezetimibe ezetimibe E Ez Eze Ezet e be ibe mibe BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
/ / / / / / / / / / BLOCKIN LINEIN LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 11 10 0
simvastatin+ezetimibe simvastatin+ezetimibe s si sim simv e be ibe mibe BLOCKEND LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
CETP cetp C CE CET CETP P TP ETP CETP BLOCKSTART LINESTART LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 11 10 0
inhibitors inhibitors i in inh inhi s rs ors tors BLOCKEND LINEEND LINEINDENT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
2012 2012 2 20 201 2012 2 12 012 2012 BLOCKSTART LINESTART LINEINDENT NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 NOPUNCT 11 9 0
2002 2002 2 20 200 2002 2 02 002 2002 BLOCKEND LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 NOPUNCT 11 9 0
Figure figure F Fi Fig Figu e re ure gure BLOCKSTART LINESTART ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
2 2 2 2 2 2 2 2 2 2 BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 NOPUNCT 11 10 0
| | | | | | | | | | BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 NOPUNCT 11 10 0
Market market M Ma Mar Mark t et ket rket BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
drugs drugs d dr dru drug s gs ugs rugs BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
to to t to to to o to to to BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
treat treat t tr tre trea t at eat reat BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
dyslipidaemia dyslipidaemia d dy dys dysl a ia mia emia BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
in in i in in in n in in in BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
US us U US US US S US US US BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 NOPUNCT 11 10 0
$ $ $ $ $ $ $ $ $ $ BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 NOPUNCT 11 10 0
billion billion b bi bil bill n on ion lion BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 DOT 11 10 0
Other other O Ot Oth Othe r er her ther BLOCKIN LINEIN ALIGNEDLEFT NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
lipid lipid l li lip lipi d id pid ipid BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 11 10 0
modifying modifying m mo mod modi g ng ing ying BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
treatments treatments t tr tre trea s ts nts ents BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
include include i in inc incl e de ude lude BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
fibrates fibrates f fi fib fibr s es tes ates BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
and and a an and and d nd and and BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
bile bile b bi bil bile e le ile bile BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
- - - - - - - - - - BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 HYPHEN 11 10 0
acid acid a ac aci acid d id cid acid BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
sequestrants sequestrants s se seq sequ s ts nts ants BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 10 0
Data data D Da Dat Data a ta ata Data BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
are are a ar are are e re are are BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
for for f fo for for r or for for BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
the the t th the the e he the the BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
seven seven s se sev seve n en ven even BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
major major m ma maj majo r or jor ajor BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
markets markets m ma mar mark s ts ets kets BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 10 0
( ( ( ( ( ( ( ( ( ( BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 OPENBRACKET 11 10 0
United united U Un Uni Unit d ed ted ited BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
States states S St Sta Stat s es tes ates BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 10 0
France france F Fr Fra Fran e ce nce ance BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 10 0
, , , , , , , , , , BLOCKIN LINEEND ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 10 0
Germany germany G Ge Ger Germ y ny any many BLOCKIN LINESTART ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 11 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 11 0
Italy italy I It Ita Ital y ly aly taly BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 11 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 11 0
Spain spain S Sp Spa Spai n in ain pain BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 11 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 11 0
United united U Un Uni Unit d ed ted ited BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 11 0
Kingdom kingdom K Ki Kin King m om dom gdom BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 11 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 11 0
Japan japan J Ja Jap Japa n an pan apan BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 NOPUNCT 11 11 0
) ) ) ) ) ) ) ) ) ) BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 ENDBRACKET 11 11 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 11 0
CETP cetp C CE CET CETP P TP ETP CETP BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 NOPUNCT 11 11 0
, , , , , , , , , , BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 COMMA 11 11 0
cholesteryl cholesteryl c ch cho chol l yl ryl eryl BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 11 0
ester ester e es est este r er ter ster BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 11 0
transferase transferase t tr tra tran e se ase rase BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 11 0
protein protein p pr pro prot n in ein tein BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 NOPUNCT 11 11 0
. . . . . . . . . . BLOCKIN LINEIN ALIGNEDLEFT SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 DOT 11 11 0

